Press Releases

Press Releases

or

December 13, 2019
- Oral presentation on data from Phase 1b trial in patients with platinum-resistant ovarian cancer CAMBRIDGE, Mass. and BEIJING, China , Dec. 13, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and
November 26, 2019
CAMBRIDGE, Mass. and BEIJING, China , Nov. 26, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today
November 12, 2019
CAMBRIDGE, Mass. and BEIJING, China , Nov. 12, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today